Cystic Fibrosis Foundation - Click here for homepage
Stay Informed  |  Volunteer  |  Clinical Trials

In This Section

Quick Links

Find a Chapter

Get Assistance

Get Assistance - Cox Boys
We are here to help people with CF get the insurance coverage they need. Hear how the Foundation helped the Cox family.

Join us on Facebook!  Facebook 
Follow us on Twitter!  Twitter 
Follow us on Instagram!  Instagram 
Add us to your circle in Google+!

Google+ 

Subscribe to our channel on YouTube!  YouTube  


 

 

Print  

NIH Director Francis Collins to Address 3,000 Cystic Fibrosis Experts at International Conference in Minneapolis

October 8, 2009

Francis S. Collins, M.D., Ph.D., the new NIH director who led an international effort to map the human genome and co-discovered the gene responsible for cystic fibrosis, will address more than 3,000 leading scientists and clinicians from around the world at the 23rd annual North American Cystic Fibrosis Conference (NACFC).

Held in Minneapolis from Oct. 15-17, 2009, the conference comes at a pivotal point in the history of cystic fibrosis, a fatal genetic disease.

For the first time, drugs that aim to treat the basic genetic defect in CF have reached Phase 3 clinical trials. These include VX-770ataluren (formerly PTC124) and denufosol. Past NACFC conferences have fueled this progress, and helped life expectancy for people with CF to double over the past 25 years.

The Cystic Fibrosis Foundation is an accredited charity of the Better Business Bureau.